Global Wellness Strategies Inc. appointed Dr. Keane as its Key Opinion Leader (KOL) to guide its study methodology and choice of efficacy endpoints for the Shanti trials. Associate Professor Michael Keane is a specialist anesthesiologist with academic appointments at Swinburne University and Monash University in Australia. Professor Keane brings two decades of research experience across a wide variety of clinical and scientific disciplines. Additionally, he is the author of multiple MDMA articles, published in peer-reviewed scientific journals.